All In MedTech

FDA Clearance Tracker · P050019-S008

CARTOID WALLSTENT MONORAIL ENDOPROSTHESIS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 27, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P050019-S008
Device name
CARTOID WALLSTENT MONORAIL ENDOPROSTHESIS
Applicant location
Maple Grove, MN
Received
Jul 15, 2011
Decided
Jan 27, 2012
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P050019

Device type

Device class
Class III

Every decision under product code NIM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE LABELING TO INCLUDE THE POST-APPROVAL STUDY FINDINGS.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.